Certara's scientific consultants support strategic drug development decisions and submission-ready analyses.
From Discovery through Development
Supporting Thirteen Recent Drug Approvals with Model Based Drug Development
Certara’s Pharsight Consulting Services is applying quantative models to decision making, helping accelerate FDA approvals.
Certara's global consulting team has unparalleled experience across all development phases and in all major therapeutic areas, spanning 80+ disease indications and 130 drug classes. We have collaborated with clients to support key trial design and program-level development decisions at every point along the regulatory timeline.
Our team has especially broad and deep expertise in the following therapeutic domains.